Relmada Therapeutics, Inc. Share Price
RLMDRelmada Therapeutics, Inc. Stock Performance
Open $5.32 | Prev. Close $5.21 | Circuit Range N/A |
Day Range $4.96 - $5.46 | Year Range $0.56 - $7.99 | Volume 1,63,502 |
Average Traded $5.13 |
Relmada Therapeutics, Inc. Share Price Chart
About Relmada Therapeutics, Inc.
Relmada Therapeutics, Inc. operates as a clinical-stage biotechnology company in the United States. The company focuses on the development of NDV-01, a controlled-release intravesical formulation of gemcitabine and docetaxel, which is in Phase 2 clinical trial for patients with aggressive forms of non-muscle invasive bladder cancer; and sepranolone, a neurosteroid epimer of allopregnanolone, which is Phase 2b-ready for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor, and other diseases related to excessive GABAergic activity. It also develops REL-P11, a modified-release formulation of psilocybin that has completed Phase 1 safety study for the treatment of metabolic disease. Relmada Therapeutics, Inc. was founded in 2004 and is headquartered in Coral Gables, Florida.
Relmada Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
20-Jul-26 | $5.32 | $5.00 | +0.00% |
20-Jul-26 | $5.32 | $5.00 | -4.40% |
17-Jul-26 | $5.35 | $5.22 | -4.30% |
16-Jul-26 | $6.24 | $5.46 | -11.79% |
15-Jul-26 | $6.16 | $6.19 | -0.32% |
14-Jul-26 | $6.45 | $6.21 | -3.57% |
13-Jul-26 | $6.38 | $6.44 | +0.63% |
FAQs on Relmada Therapeutics, Inc. Share Price
Can I buy Relmada Therapeutics, Inc. shares in India?
What is the share price of Relmada Therapeutics, Inc.?
What is the 5 year returns of Relmada Therapeutics, Inc.?
What are the high & low stock price of Relmada Therapeutics, Inc. today?
What is the 52-week high and low of Relmada Therapeutics, Inc. stock?